These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8558511)

  • 1. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R.
    Haskell-Luevano C; Miwa H; Dickinson C; Hadley ME; Hruby VJ; Yamada T; Gantz I
    J Med Chem; 1996 Jan; 39(2):432-5. PubMed ID: 8558511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
    Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
    J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships of novel alpha-melanocyte-stimulating hormone inhibitors.
    Sawyer TK; Staples DJ; Castrucci AM; Hadley ME
    Pept Res; 1989; 2(1):140-6. PubMed ID: 2562482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.
    Haskell-Luevano C; Miwa H; Dickinson C; Hruby VJ; Yamada T; Gantz I
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1137-42. PubMed ID: 7980588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
    Getting SJ; Schiöth HB; Perretti M
    J Pharmacol Exp Ther; 2003 Aug; 306(2):631-7. PubMed ID: 12750433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.
    Haskell-Luevano C; Boteju LW; Miwa H; Dickinson C; Gantz I; Yamada T; Hadley ME; Hruby VJ
    J Med Chem; 1995 Nov; 38(23):4720-9. PubMed ID: 7473600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist.
    Han G; Quillan JM; Carlson K; Sadée W; Hruby VJ
    J Med Chem; 2003 Feb; 46(5):810-9. PubMed ID: 12593660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biological activities of potent analogues of alpha-melanotropin. Effect of nonaromatic and para substituted aromatic amino acids at position 7.
    Wilkes BC; Cody WL; Hruby VJ; Castrucci AM; Hadley ME
    Int J Pept Protein Res; 1986 Jun; 27(6):685-94. PubMed ID: 3489682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
    Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
    Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biological activities of alpha-MSH antagonists in vertebrate pigment cells.
    Castrucci AM; Almeida AL; al-Obeidi FA; Hadley ME; Hruby VJ; Staples DJ; Sawyer TK
    Gen Comp Endocrinol; 1997 Mar; 105(3):410-6. PubMed ID: 9073503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New melanocortin 1 receptor binding motif based on the C-terminal sequence of alpha-melanocyte-stimulating hormone.
    Schiöth HB; Muceniece R; Mutule I; Wikberg JE
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):287-93. PubMed ID: 17040213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.